MedPath

Improving Bladder Function in SCI by Neuromodulation

Not Applicable
Recruiting
Conditions
Spinal Cord Injury
Interventions
Device: Electromagnetic Neuromodulation
Registration Number
NCT02331979
Lead Sponsor
University of California, Los Angeles
Brief Summary

This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury.

Detailed Description

This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury. Neuromodulation will be in the form of transcutaneous electrical stimulation and/or magnetic stimulation.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
24
Inclusion Criteria
  1. Male 18-45 years;
  2. At least 1 year post-injury;
  3. Non-progressive SCI at C2-T8 (non-conus injury);
  4. Motor Complete ASIA (A or B);
  5. Neurogenic bladder requiring clean intermittent straight catheterization;
  6. Able to attend twice weekly testing sessions for 6 months.
  7. Have intact lower extremity anatomy and able to use lower extremity for assistive standing and stepping.
Read More
Exclusion Criteria
  1. History of autonomic dysreflexia;

  2. Ventilator dependency;

  3. Musculoskeletal dysfunction, unhealed fracture, pressure ulcer, active infection;

  4. Clinically significant depression or ongoing drug abuse;

  5. Received botox injection, or bladder surgery (suprapubic access, Brindley procedure, etc.); 6. Prostatic hypertrophy or bladder outlet disorder;

  6. Cardiopulmonary disease that precludes lower extremity training or rehabilitation.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stimulation of Non-NaiveElectromagnetic NeuromodulationEvaluate neuromodulation in 6 subjects with prior motor training.
StimulationElectromagnetic NeuromodulationApply parameters discovered in Arm 1 and Arm 2 to evaluate neuromodulation in 12 naive subjects.
Stimulation of NaiveElectromagnetic NeuromodulationEvaluate neuromodulation in 6 naive subjects.
Primary Outcome Measures
NameTimeMethod
Urine flow and volumeMonths 1-48
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of California, Los Angeles

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath